article thumbnail

Teknova unveils new manufacturing facility for high-quality reagents

BioPharma Reporter

Teknova, a producer of life science reagents, has opened a new GMP-certified production facility which it claims will enable bioprocessing and gene therapy companies to get into the clinic faster.

Reagent 97
article thumbnail

BMS and Prime ink potential $3.5bn deal to develop T cell therapies

Pharmaceutical Technology

As part of the deal, which could be worth $3.5bn, BMS will gain developmental support and therapeutic reagents from Prime Medicine.

Reagent 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Merck KGaA to buy gene therapy tools maker for $600M

Bio Pharma Dive

The German drugmaker is bolstering its MilliporeSigma business with a unit of Gamma Biosciences that specializes in so-called transfection reagents.

article thumbnail

Global Research Antibodies and Reagents Market Forecasts, 2020-2027: Focus on Antibodies, Production, Source, Research Area, Reagents, ELISA, Western Blot – ResearchAndMarkets.com

BioTech 365

Global Research Antibodies and Reagents Market Forecasts, 2020-2027: Focus on Antibodies, Production, Source, Research Area, Reagents, ELISA, Western Blot – ResearchAndMarkets.com Global Research Antibodies and Reagents Market Forecasts, 2020-2027: Focus on Antibodies, Production, Source, Research Area, Reagents, ELISA, Western Blot … Continue (..)

Reagent 40
article thumbnail

PerkinElmer Completes Acquisition of Antibody and Reagent Leader BioLegend

BioTech 365

PerkinElmer Completes Acquisition of Antibody and Reagent Leader BioLegend PerkinElmer Completes Acquisition of Antibody and Reagent Leader BioLegend WALTHAM, Mass.–(BUSINESS –(BUSINESS WIRE)–PerkinElmer, Inc.

Reagent 52
article thumbnail

SpeeDx Build Further Coverage in SARS-CoV-2 Genotyping Reagent Portfolio

BioTech 365

SpeeDx Build Further Coverage in SARS-CoV-2 Genotyping Reagent Portfolio SpeeDx Build Further Coverage in SARS-CoV-2 Genotyping Reagent Portfolio Rapid development of key mutation detection reagents continues to facilitate critical investigation and monitoring activities SYDNEY–(BUSINESS WIRE)–#COVID19–SpeeDx Pty.

article thumbnail

New COVID test doesn’t use scarce reagents, catches all but the least infectious

Scienmag

Addresses major testing need in developing world; also in US, where reagent supplies are again dwindling Credit: Brian Jenkins A major roadblock to large scale testing for coronavirus infection in the developing world is a shortage of key chemicals, or reagents, needed for the test, specifically the ones used to extract the virus’s genetic material, (..)

Reagent 52